$2.63 Billion is the total value of Perceptive Advisors's 101 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 63.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $315,363,000 | -46.3% | 4,608,554 | -3.5% | 12.00% | -23.6% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $222,726,000 | +13.8% | 5,425,726 | +5.4% | 8.48% | +62.0% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $191,701,000 | -23.4% | 20,724,424 | +0.1% | 7.30% | +9.1% |
| ZGNX | Sell | ZOGENIX INC | $138,191,000 | -26.8% | 3,790,216 | -0.5% | 5.26% | +4.1% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $108,333,000 | +32.1% | 12,241,111 | +67.9% | 4.12% | +88.0% |
| SLDB | New | SOLID BIOSCIENCES INC | $105,249,000 | – | 3,927,222 | +100.0% | 4.01% | – |
| CRNX | CRINETICS PHARMACEUTICALS INC | $77,612,000 | +4.7% | 2,587,953 | 0.0% | 2.95% | +49.0% | |
| QTNT | Buy | QUOTIENT LTD | $66,029,000 | -0.5% | 10,789,054 | +22.8% | 2.51% | +41.7% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $64,553,000 | +550.2% | 4,875,600 | +699.0% | 2.46% | +827.2% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $63,043,000 | -17.1% | 1,052,647 | -1.9% | 2.40% | +18.1% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $55,605,000 | -11.6% | 1,430,171 | +4.6% | 2.12% | +25.8% |
| ARGX | ARGENX SEsponsored adr | $53,889,000 | +26.7% | 560,941 | 0.0% | 2.05% | +80.2% | |
| MYOK | Sell | MYOKARDIA INC | $53,503,000 | -24.7% | 1,075,216 | -1.3% | 2.04% | +7.2% |
| MMSI | Sell | MERIT MEDICAL SYSTEMS INC | $52,177,000 | -14.6% | 949,198 | -4.5% | 1.99% | +21.5% |
| RTRX | Buy | RETROPHIN INC | $49,782,000 | -17.7% | 3,342,038 | +4.0% | 1.90% | +17.2% |
| MGTX | MEIRAGTX HOLDINGS PLC | $45,340,000 | -29.1% | 4,703,398 | 0.0% | 1.73% | +0.9% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $43,588,000 | -11.5% | 2,911,715 | +9.4% | 1.66% | +26.0% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $43,484,000 | -40.8% | 857,326 | -8.9% | 1.66% | -15.7% |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $41,574,000 | – | 1,543,790 | +100.0% | 1.58% | – |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $41,022,000 | -52.8% | 4,313,611 | 0.0% | 1.56% | -32.8% | |
| XLRN | Sell | ACCELERON PHARMA INC | $39,938,000 | -54.3% | 905,017 | -40.8% | 1.52% | -35.0% |
| ALBO | ALBIREO PHARMA INC | $39,506,000 | -29.7% | 1,704,330 | 0.0% | 1.50% | +0.1% | |
| VBIV | Buy | VBI VACCINES INC | $38,322,000 | +63.8% | 23,951,556 | +147.8% | 1.46% | +133.3% |
| ATNX | Buy | ATHENEX INC | $32,550,000 | -27.0% | 5,096,022 | +77.6% | 1.24% | +3.9% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $31,132,000 | +4734.2% | 2,825,000 | +11435.8% | 1.18% | +6870.6% |
| VRCA | VERRICA PHARMACEUTICALS INC | $27,794,000 | -49.8% | 3,410,412 | 0.0% | 1.06% | -28.6% | |
| KDMN | KADMON HLDGS INC | $27,384,000 | -37.7% | 13,165,746 | 0.0% | 1.04% | -11.4% | |
| RGNX | Buy | REGENXBIO INC | $26,894,000 | -24.3% | 645,726 | +37.2% | 1.02% | +7.8% |
| ALDX | ALDEYRA THERAPEUTICS INC | $24,684,000 | -42.0% | 3,085,458 | 0.0% | 0.94% | -17.6% | |
| VAPO | New | VAPOTHERM INC | $24,464,000 | – | 1,226,315 | +100.0% | 0.93% | – |
| DOVA | DOVA PHARMACEUTICALS INC | $23,693,000 | -63.9% | 3,125,851 | 0.0% | 0.90% | -48.5% | |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $22,823,000 | – | 1,873,779 | +100.0% | 0.87% | – |
| KOD | New | KODIAK SCIENCES INC | $22,259,000 | – | 3,135,199 | +100.0% | 0.85% | – |
| VRAY | Buy | VIEWRAY INC | $21,715,000 | -37.3% | 3,905,650 | +5.6% | 0.83% | -10.8% |
| NVTA | Buy | INVITAE CORP | $20,609,000 | -33.8% | 1,863,406 | +0.1% | 0.78% | -5.9% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $19,382,000 | -36.2% | 2,462,821 | -10.2% | 0.74% | -9.2% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $18,462,000 | -82.4% | 262,241 | -78.1% | 0.70% | -74.9% |
| NEPT | NEPTUNE WELLNESS SOLUTIONS I | $17,849,000 | -48.3% | 8,891,452 | 0.0% | 0.68% | -26.4% | |
| CMTA | New | CLEMENTIA PHARMACEUTICALS INC | $17,640,000 | – | 1,500,000 | +100.0% | 0.67% | – |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $15,878,000 | +3.8% | 614,242 | -3.3% | 0.60% | +47.7% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $15,850,000 | -11.0% | 4,661,824 | +50.0% | 0.60% | +26.7% |
| ADMA | ADMA BIOLOGICS INC | $14,542,000 | -64.1% | 6,521,102 | 0.0% | 0.55% | -48.9% | |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $13,763,000 | -29.0% | 509,186 | -23.3% | 0.52% | +1.2% |
| New | AQUESTIVE THERAPEUTICS INC | $13,314,000 | – | 2,113,400 | +100.0% | 0.51% | – | |
| SAGE | New | SAGE THERAPEUTICS INC | $13,110,000 | – | 147,315 | +100.0% | 0.50% | – |
| MEIP | New | MEI PHARMA INC | $11,617,000 | – | 4,400,440 | +100.0% | 0.44% | – |
| PRQR | Sell | PROQR THERAPEUTICS N.V. | $11,250,000 | -23.6% | 722,523 | -5.1% | 0.43% | +8.6% |
| MRKR | New | MARKER THERAPEUTICS INC | $11,100,000 | – | 2,000,000 | +100.0% | 0.42% | – |
| AXNX | New | AXONICS MODULATION TECH INC | $10,935,000 | – | 751,000 | +100.0% | 0.42% | – |
| IMMU | Buy | IMMUNOMEDICS INC | $10,500,000 | +2264.9% | 700,000 | +3181.0% | 0.40% | +3233.3% |
| MOTS | Buy | MOTUS GI HOLDINGS INC | $9,984,000 | -30.3% | 3,210,542 | +14.2% | 0.38% | -0.8% |
| EIDX | EDIOS THERAPEUTICS INC | $9,452,000 | +37.9% | 686,922 | 0.0% | 0.36% | +96.7% | |
| Buy | PROTAGONIST THERAPEUTICS INC | $9,190,000 | -16.2% | 1,365,579 | +28.1% | 0.35% | +19.5% | |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $9,182,000 | -57.5% | 1,703,440 | -30.5% | 0.35% | -39.6% |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $8,207,000 | – | 521,800 | +100.0% | 0.31% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $7,374,000 | – | 445,000 | +100.0% | 0.28% | – |
| ANI PHARMACEUTICALS INCnote 3.000%12/0 | $7,383,000 | -7.0% | 7,500,000 | 0.0% | 0.28% | +32.5% | ||
| ZYME | Sell | ZYMEWORKS INC | $7,196,000 | -57.4% | 573,890 | -48.9% | 0.27% | -39.4% |
| MTEM | MOLECULAR TEMPLATES INC | $7,107,000 | -33.2% | 1,974,133 | 0.0% | 0.27% | -5.3% | |
| XNCR | Sell | XENCOR INC | $6,833,000 | -78.8% | 196,810 | -76.2% | 0.26% | -69.9% |
| SYBX | Sell | SYNLOGIC INC | $6,049,000 | -54.9% | 867,852 | -8.0% | 0.23% | -35.8% |
| QURE | Sell | UNIQURE NV | $5,946,000 | -83.2% | 220,707 | -77.3% | 0.23% | -76.1% |
| TXMD | THERAPEUTICSMD INC | $5,715,000 | -41.9% | 1,500,000 | 0.0% | 0.22% | -17.1% | |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $5,309,000 | -92.1% | 826,960 | -72.5% | 0.20% | -88.8% |
| MRTX | New | MIRATI THERAPEUTICS INC | $5,250,000 | – | 125,875 | +100.0% | 0.20% | – |
| UROV | Buy | UROVANT SCIENCES LTD | $3,915,000 | -29.5% | 625,359 | +35.2% | 0.15% | +0.7% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $3,582,000 | -48.9% | 300,000 | -17.9% | 0.14% | -27.3% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $3,495,000 | – | 240,173 | +100.0% | 0.13% | – |
| SRRA | Sell | SIERRA ONCOLOGY INC | $3,413,000 | -37.3% | 2,666,190 | -16.7% | 0.13% | -10.3% |
| TBIO | Sell | TRANSLATE BIO INC | $3,167,000 | -36.7% | 435,000 | -13.0% | 0.12% | -9.7% |
| TDOC | New | TELADOC HEALTH INC | $2,974,000 | – | 60,000 | +100.0% | 0.11% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $2,501,000 | -78.6% | 59,498 | -74.6% | 0.10% | -69.6% |
| EHTH | Sell | EHEALTH INC | $2,113,000 | -66.9% | 55,021 | -75.7% | 0.08% | -53.2% |
| PEN | New | PENUMBRA INC | $2,037,000 | – | 16,338 | +100.0% | 0.08% | – |
| VERU | VERU INC | $1,853,000 | -8.4% | 1,425,000 | 0.0% | 0.07% | +31.5% | |
| ACST | New | ACASTI PHARMA INCcl a new | $1,480,000 | – | 1,779,882 | +100.0% | 0.06% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $1,421,000 | -24.9% | 139,890 | -11.3% | 0.05% | +5.9% |
| OMED | Sell | ONCOMED PHARMACEUTICALS INC | $1,284,000 | -76.9% | 1,719,111 | -34.4% | 0.05% | -67.1% |
| ABEOW | ABEONA THERAPEUTICS INCw exp12/24/201 | $1,267,000 | -75.4% | 659,636 | 0.0% | 0.05% | -65.2% | |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $1,269,000 | -58.8% | 180,797 | -24.8% | 0.05% | -41.5% |
| CDNA | Sell | CAREDX INC | $1,037,000 | -86.2% | 44,128 | -83.1% | 0.04% | -80.6% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $960,000 | – | 300,000 | +100.0% | 0.04% | – |
| FCAU | FIAT CHRYSLER AUTOMOBILES N. | $894,000 | -17.7% | 62,000 | 0.0% | 0.03% | +17.2% | |
| IVC | INVACARE CORP | $860,000 | -70.4% | 200,000 | 0.0% | 0.03% | -57.7% | |
| ALNA | Sell | ALLENA PHARMACEUTICALS INC | $704,000 | -73.8% | 132,300 | -47.1% | 0.03% | -62.5% |
| PERNIX THERAPEUTICS HLDGS INdbcv 4,250% 4/0 | $642,000 | +55.4% | 1,000,000 | 0.0% | 0.02% | +118.2% | ||
| RACE | FERRARI N.V. | $610,000 | -28.2% | 6,200 | 0.0% | 0.02% | 0.0% | |
| VCEL | Buy | VERICEL CORP | $488,000 | +26.8% | 28,090 | +3.2% | 0.02% | +90.0% |
| TNDM | New | TANDEM DIABETES CARE INC | $479,000 | – | 12,844 | +100.0% | 0.02% | – |
| DXCM | New | DEXCOM INC | $442,000 | – | 3,733 | +100.0% | 0.02% | – |
| GKOS | New | GLAUKOS CORP | $417,000 | – | 7,466 | +100.0% | 0.02% | – |
| ZGNX | New | ZOGENIX INCput | $410,000 | – | 200,000 | +100.0% | 0.02% | – |
| AMED | New | AMEDISYS INC | $422,000 | – | 3,672 | +100.0% | 0.02% | – |
| STAA | New | STAAR SURGICAL CO | $405,000 | – | 12,953 | +100.0% | 0.02% | – |
| SIBN | New | SI-BONE INC | $307,000 | – | 15,000 | +100.0% | 0.01% | – |
| IMMU | New | IMMUNOMEDICS INCcall | $308,000 | – | 200,000 | +100.0% | 0.01% | – |
| ALQA | Sell | ALLIQUA BIOMEDICAL INC | $214,000 | -77.7% | 114,730 | -72.9% | 0.01% | -69.2% |
| VCNX | VACCINEX INC | $190,000 | -47.9% | 50,000 | 0.0% | 0.01% | -30.0% | |
| OTLKW | New | OUTLOOK THERAPEUTICS INC*w exp 02/18/201 | $72,000 | – | 420,875 | +100.0% | 0.00% | – |
| SLDB | New | SOLID BIOSCIENCES INCcall | $14,000 | – | 1,835 | +100.0% | 0.00% | – |
| ONCS | ONCOSEC MEDICAL INC | $32,000 | -54.3% | 50,000 | 0.0% | 0.00% | -50.0% | |
| ONSIW | Exit | ONCOBIOLOGICS INC*w exp 02/18/201 | $0 | – | -420,875 | -100.0% | 0.00% | – |
| CAPR | Exit | CAPRICOR THERAPEUTICS INC | $0 | – | -4,000 | -100.0% | 0.00% | – |
| GERN | Exit | GERON CORPcall | $0 | – | -200,000 | -100.0% | 0.00% | – |
| Exit | SOLID BIOSCIENCES INCcall | $0 | – | -1,835 | -100.0% | -0.00% | – | |
| CASI | Exit | CASI PHARMACEUTICALS INC | $0 | – | -43,682 | -100.0% | -0.01% | – |
| HCM | Exit | HUTCHISON CHINA MEDITECH LTDsponsored adr | $0 | – | -10,000 | -100.0% | -0.01% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -2,213 | -100.0% | -0.01% | – |
| PRTO | Exit | PROTEON THERAPEUTICS INC | $0 | – | -240,488 | -100.0% | -0.01% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -137,500 | -100.0% | -0.01% | – |
| BLFS | Exit | BIOLIFE SOLUTIONS INC | $0 | – | -29,376 | -100.0% | -0.01% | – |
| SENS | Exit | SENSEONICS HLDGS INC | $0 | – | -115,000 | -100.0% | -0.02% | – |
| NTRA | Exit | NATERA INC | $0 | – | -24,000 | -100.0% | -0.02% | – |
| HSGX | Exit | HISTOGENICS CORP | $0 | – | -1,203,399 | -100.0% | -0.02% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -5,627 | -100.0% | -0.02% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -14,055 | -100.0% | -0.02% | – |
| RETA | Exit | REATA PHARMACEUTICALS INC | $0 | – | -9,677 | -100.0% | -0.02% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -19,367 | -100.0% | -0.02% | – |
| CSU | Exit | CAPITAL SR LIVING CORP | $0 | – | -100,173 | -100.0% | -0.02% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -5,700 | -100.0% | -0.03% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -64,261 | -100.0% | -0.03% | – |
| TRHC | Exit | TABULA RASA HEALTHCARE INC | $0 | – | -14,663 | -100.0% | -0.03% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -53,169 | -100.0% | -0.04% | – |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -125,000 | -100.0% | -0.06% | – |
| NVTRQ | Exit | NUVECTRA CORP | $0 | – | -135,000 | -100.0% | -0.08% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -110,000 | -100.0% | -0.08% | – |
| XERS | Exit | XERIS PHARMACEUTICALS INC | $0 | – | -200,627 | -100.0% | -0.09% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| GERN | Exit | GERON CORPput | $0 | – | -1,950,000 | -100.0% | -0.10% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -135,500 | -100.0% | -0.12% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -150,000 | -100.0% | -0.12% | – |
| PTE | Exit | POLARITYTE INC | $0 | – | -336,818 | -100.0% | -0.17% | – |
| TSRO | Exit | TESARO INC | $0 | – | -200,000 | -100.0% | -0.21% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -422,015 | -100.0% | -0.23% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -907,732 | -100.0% | -0.24% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -23,800 | -100.0% | -0.29% | – |
| HUM | Exit | HUMANA INC | $0 | – | -35,000 | -100.0% | -0.32% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -111,000 | -100.0% | -0.37% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -168,939 | -100.0% | -0.43% | – |
| AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -1,150,000 | -100.0% | -0.54% | – |
| BHVN | Exit | BIOHAVEN PHARMACEUTICAL HLDG CO L | $0 | – | -990,943 | -100.0% | -1.00% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -72,500 | -100.0% | -1.11% | – |
| ECYT | Exit | ENDOCYTE INC REGISTERED SHS | $0 | – | -2,441,700 | -100.0% | -1.16% | – |
| CORI | Exit | CORIUM INTERNATIONAL INC | $0 | – | -6,357,133 | -100.0% | -1.62% | – |
| Exit | SOLID BIOSCIENCES INC | $0 | – | -3,927,222 | -100.0% | -4.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.